GlassScriptPhysician profile
Anna T Payne
NPI 1952054363
$1,894.61
in general payments reported to CMS, 2019-2025
25 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $501 · 2023: $575 · 2024: $568 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,393.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $351.65 | 2022-2024 | Wegovy |
| Mayne Pharma Commercial LLC | $253.03 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $199.73 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $145.97 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $119.56 | 2023-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Biohaven Pharmaceutical Holding Company LTD. | $104.77 | 2022 | |
| Coopersurgical, INC. | $100.34 | 2022-2024 | Paragard T 380a, Paragard T 380a, Wallach Cryosurgical Equipment |
| Pfizer INC. | $97.34 | 2023-2024 | |
| Agile Therapeutics, INC. | $90.70 | 2022-2024 | Twirla |
| Myovant Sciences INC. | $82.00 | 2022 | |
| Abbvie INC. | $48.32 | 2022-2023 | |
| Shield Therapeutics INC | $44.89 | 2023-2024 | Accrufer |
| Arjo INC. | $26.82 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $24.57 | 2023 | Exparel |
| Lilly USA, LLC | $22.93 | 2024 | Zepbound, Jardiance |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $22.57 | 2024 | |
| Avion Pharmaceuticals | $22.48 | 2023 | Balcoltra |
| Amgen INC. | $21.10 | 2024 | Prolia, Evenity |
| Dysis Medical, INC. | $19.73 | 2022 | |
| Exact Sciences Corporation | $19.39 | 2023 | Cologuard Collection Kit |
| Biogen, INC. | $16.66 | 2025 | Zurzuvae |
| Therapeuticsmd, INC. | $16.10 | 2022 | |
| Currax Pharmaceuticals LLC | $15.75 | 2023 | Nexletol, Onzetra Xsail, Nexlizet |
| Astellas Pharma US INC | $15.21 | 2024 | Veozah |
| Scynexis, INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.